Stocks as well as other types of risk assets took a hit this week. Situation improved slightly by the end of the week as the ECB persuaded investors that it is not tapering yet. While there are no decisions from major central banks scheduled for the upcoming week, top-tier economic reports from the United States will be released. Be sure to watch DE30, GOLD and US100 next week.
DE30
Global equities pulled back this week amid concerns that major central banks will begin tapering asset purchases. While ECB slowed pace of its emergency purchases, President Lagarde assured markets that it is not tapering but a recalibration. Investor seem to have believe in this explanation as indices began to recover. However, is reasoning behind this recovery solid enough to push DE30 to fresh all-time highs?
GOLD
Gold prices took a strong hit at the beginning of this week along with equity markets. However, unlike stocks, the precious metal failed to recover in the later part of the week. Price has been stuck near the $1,800 mark and struggled to produce a bigger move in either direction. US CPI data for August will be released next Tuesday at 1:30 pm BST. Will data finally show a slowdown that the Fed is so much looking for? Or is another acceleration coming that gold price would not see as welcome?
US100
US tech index Nasdaq-100 (US100) has proved to be somewhat more resilient during this week's sell-off than other indices from Wall Street. In spite of sky-high valuations, tech stocks continue to perform well and ignore deteriorating data. Next week investors will be offered retail sales data for August from the United States with median estimates pointing to a slight drop on a month-over month basis. However, as federal unemployment benefits start to expire there is a risk of a bigger hit.
Daily Summary: Technology Drives Wall Street to Record Highs Despite Tensions in the Persian Gulf
🔴 Three markets to watch next week: EURUSD, CH50cash, OIL (08.05.2026)
US Open: Earnings season and strong NFP report drive Wall Street higher!
Nasdaq surges 0.8% at historic high📈How strong is the US earnings season?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
